Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following transactions by managerial staff:
The Board of Directors has previously granted share options and performance shares in ALK-Abelló A/S, re. company release no. 08/2023 of 31 March 2023. The right to share options and performance shares may be achieved in April 2026, provided that ALK achieves the pre-agreed targets for vesting and that the employment relationship with the ALK Group has not been terminated by the company on objective grounds or terminated.
The final calculations have now been completed, and final allocation of share options and delivery of performance shares have taken place as stated in the attached pdf file.
Attachment
Latest Health & Supplement Reviews
- YuSleep Reviews (EXPOSED) Doctor Explains Deep Sleep Benefits, Hidden Risks & Real Consumers Results In 2026
- Neuro Energizer Reviews and Complaints 2026: How This Neuro-Sonic Breakthrough Is Reshaping Cognitive Therapy, Memory & Daily Focus
- Gluco6 Reviews and Complaints (March 2026) Real User Data on Natural Blood Sugar Balance and Glucose Stability